Summit Global Investments Mannkind Corp Transaction History
Summit Global Investments
- $1.34 Billion
- Q1 2024
A detailed history of Summit Global Investments transactions in Mannkind Corp stock. As of the latest transaction made, Summit Global Investments holds 13,901 shares of MNKD stock, worth $72,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,901
Previous 13,901
-0.0%
Holding current value
$72,563
Previous $51,000
23.53%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding MNKD
# of Institutions
209Shares Held
130MCall Options Held
1.81MPut Options Held
808K-
Black Rock Inc. New York, NY21.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$79 Million0.0% of portfolio
-
State Street Corp Boston, MA11.9MShares$62.3 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY10.1MShares$52.6 Million4.85% of portfolio
-
Avoro Capital Advisors LLC New York, NY9MShares$47 Million0.49% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.34B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...